141 related articles for article (PubMed ID: 29197543)
1. Role of dopamine D1 receptor in 3-fluoromethamphetamine-induced neurotoxicity in mice.
Nguyen PT; Shin EJ; Dang DK; Tran HQ; Jang CG; Jeong JH; Lee YJ; Lee HJ; Lee YS; Yamada K; Nabeshima T; Kim HC
Neurochem Int; 2018 Feb; 113():69-84. PubMed ID: 29197543
[TBL] [Abstract][Full Text] [Related]
2. Methiopropamine, a methamphetamine analogue, produces neurotoxicity via dopamine receptors.
Nguyen PT; Dang DK; Tran HQ; Shin EJ; Jeong JH; Nah SY; Cho MC; Lee YS; Jang CG; Kim HC
Chem Biol Interact; 2019 May; 305():134-147. PubMed ID: 30922767
[TBL] [Abstract][Full Text] [Related]
3. The role of system Xc
Dang DK; Shin EJ; Tran HQ; Kim DJ; Jeong JH; Jang CG; Nah SY; Sato H; Nabeshima T; Yoneda Y; Kim HC
Neurochem Int; 2017 Sep; 108():254-265. PubMed ID: 28457879
[TBL] [Abstract][Full Text] [Related]
4. Genetic or pharmacological depletion of cannabinoid CB1 receptor protects against dopaminergic neurotoxicity induced by methamphetamine in mice.
Dang DK; Shin EJ; Mai AT; Jang CG; Nah SY; Jeong JH; Ledent C; Yamamoto T; Nabeshima T; Onaivi ES; Kim HC
Free Radic Biol Med; 2017 Jul; 108():204-224. PubMed ID: 28363605
[TBL] [Abstract][Full Text] [Related]
5. Ginsenoside Re protects methamphetamine-induced dopaminergic neurotoxicity in mice via upregulation of dynorphin-mediated κ-opioid receptor and downregulation of substance P-mediated neurokinin 1 receptor.
Dang DK; Shin EJ; Kim DJ; Tran HQ; Jeong JH; Jang CG; Nah SY; Jeong JH; Byun JK; Ko SK; Bing G; Hong JS; Kim HC
J Neuroinflammation; 2018 Feb; 15(1):52. PubMed ID: 29467000
[TBL] [Abstract][Full Text] [Related]
6. Role of oxidative stress in methamphetamine-induced dopaminergic toxicity mediated by protein kinase Cδ.
Shin EJ; Duong CX; Nguyen XT; Li Z; Bing G; Bach JH; Park DH; Nakayama K; Ali SF; Kanthasamy AG; Cadet JL; Nabeshima T; Kim HC
Behav Brain Res; 2012 Jun; 232(1):98-113. PubMed ID: 22512859
[TBL] [Abstract][Full Text] [Related]
7. Exposure to Far Infrared Ray Protects Methamphetamine-Induced Behavioral Sensitization in Glutathione Peroxidase-1 Knockout Mice via Attenuating Mitochondrial Burdens and Dopamine D1 Receptor Activation.
Mai HN; Sharma N; Shin EJ; Nguyen BT; Jeong JH; Jang CG; Cho EH; Nah SY; Kim NH; Nabeshima T; Kim HC
Neurochem Res; 2018 May; 43(5):1118-1135. PubMed ID: 29687308
[TBL] [Abstract][Full Text] [Related]
8. Apocynin prevents mitochondrial burdens, microglial activation, and pro-apoptosis induced by a toxic dose of methamphetamine in the striatum of mice via inhibition of p47phox activation by ERK.
Dang DK; Shin EJ; Nam Y; Ryoo S; Jeong JH; Jang CG; Nabeshima T; Hong JS; Kim HC
J Neuroinflammation; 2016 Jan; 13():12. PubMed ID: 26780950
[TBL] [Abstract][Full Text] [Related]
9. Striatal dopamine D1 and D2 receptors: widespread influences on methamphetamine-induced dopamine and serotonin neurotoxicity.
Gross NB; Duncker PC; Marshall JF
Synapse; 2011 Nov; 65(11):1144-55. PubMed ID: 21584865
[TBL] [Abstract][Full Text] [Related]
10. The role of dopamine receptors in the neurotoxicity of methamphetamine.
Ares-Santos S; Granado N; Moratalla R
J Intern Med; 2013 May; 273(5):437-53. PubMed ID: 23600399
[TBL] [Abstract][Full Text] [Related]
11. New recreational drug 1-phenyl-2-(1-pyrrolidinyl)-1-pentanone (alpha-PVP) activates central nervous system via dopaminergic neuron.
Kaizaki A; Tanaka S; Numazawa S
J Toxicol Sci; 2014 Feb; 39(1):1-6. PubMed ID: 24418703
[TBL] [Abstract][Full Text] [Related]
12. Mutual enhancement of central neurotoxicity induced by ketamine followed by methamphetamine.
Ke JJ; Chen HI; Jen CJ; Kuo YM; Cherng CG; Tsai YP; Ho MC; Tsai CW; Yu L
Toxicol Appl Pharmacol; 2008 Mar; 227(2):239-47. PubMed ID: 18076959
[TBL] [Abstract][Full Text] [Related]
13. The new designer drug buphedrone produces rewarding properties via dopamine D1 receptor activation.
Oh JH; Hwang JY; Hong SI; Ma SX; Seo JY; Lee SY; Kim HC; Jang CG
Addict Biol; 2018 Jan; 23(1):69-79. PubMed ID: 27790823
[TBL] [Abstract][Full Text] [Related]
14. Impairment in consolidation of learned place preference following dopaminergic neurotoxicity in mice is ameliorated by N-acetylcysteine but not D1 and D2 dopamine receptor agonists.
Achat-Mendes C; Anderson KL; Itzhak Y
Neuropsychopharmacology; 2007 Mar; 32(3):531-41. PubMed ID: 16760923
[TBL] [Abstract][Full Text] [Related]
15. Roles of D1 and D2 dopamine receptor subtypes in mediating the methamphetamine-induced changes in monoamine systems.
Sonsalla PK; Gibb JW; Hanson GR
J Pharmacol Exp Ther; 1986 Sep; 238(3):932-7. PubMed ID: 2943891
[TBL] [Abstract][Full Text] [Related]
16. Protective and restorative effects of the traditional Chinese medicine Jitai tablet against methamphetamine-induced dopaminergic neurotoxicity.
Xu S; Tu S; Gao J; Liu J; Guo Z; Zhang J; Liu X; Liang J; Huang Y; Han M
BMC Complement Altern Med; 2018 Feb; 18(1):76. PubMed ID: 29475448
[TBL] [Abstract][Full Text] [Related]
17. Methamphetamine oxidative stress, neurotoxicity, and functional deficits are modulated by nuclear factor-E2-related factor 2.
Ramkissoon A; Wells PG
Free Radic Biol Med; 2015 Dec; 89():358-68. PubMed ID: 26427884
[TBL] [Abstract][Full Text] [Related]
18. Methamphetamine neurotoxicity in dopamine nerve endings of the striatum is associated with microglial activation.
Thomas DM; Walker PD; Benjamins JA; Geddes TJ; Kuhn DM
J Pharmacol Exp Ther; 2004 Oct; 311(1):1-7. PubMed ID: 15163680
[TBL] [Abstract][Full Text] [Related]
19. Dopamine D2-receptor knockout mice are protected against dopaminergic neurotoxicity induced by methamphetamine or MDMA.
Granado N; Ares-Santos S; Oliva I; O'Shea E; Martin ED; Colado MI; Moratalla R
Neurobiol Dis; 2011 Jun; 42(3):391-403. PubMed ID: 21303698
[TBL] [Abstract][Full Text] [Related]
20. Electrophysiological verification of the presence of D1 and D2 dopamine receptors within the ventral pallidum.
Napier TC; Maslowski-Cobuzzi RJ
Synapse; 1994 Jul; 17(3):160-6. PubMed ID: 7974198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
